Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
QNCX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $29.86M
- EPS (TTM)
- -$214.01
- Dividend yield
- None
- 52-week range
- 15.10 – 910.00
- Day range
- 26.84 – 29.80
- Volume / Avg
- 31.84K / 28.49K
- Beta
- —
- Shares outstanding
- 1.02M
52-week range
QNCX stock today
Quince Therapeutics (QNCX) closed at $29.36 on Oct 8, up 9.88% (+$2.64), versus the S&P 500's 0.47% decline. At this level, QNCX sits near the bottom of its 52-week range of $15.10 to $910.00: 96.8% below the high, set on Dec 12, 2025 and 94.4% above the low. QNCX is down 96.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 92.5%.
Quince Therapeutics has posted a net loss over the last twelve months (EPS of -$214.01), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Quince Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- IPO year
- 2019
Quince Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EVAXEvaxion A/S ADR | 3.05 | -2.87% | $27.52M | vs QNCX |
| ATYRaTyr Pharma Inc. | 0.2553 | -8.26% | $25.04M | vs QNCX |
| ALGSAligos Therapeutics Inc. | 5.31 | -0.19% | $33.16M | vs QNCX |
| SCLXScilex Holding Company | 2.96 | -15.19% | $20.82M | vs QNCX |
| GNTAGenenta Science S.p.A. ADR | 0.7101 | -5.95% | $34.24M | vs QNCX |
| CVMCel-Sci Corporation | 1.95 | -8.45% | $34.30M | vs QNCX |
| JSPRJasper Therapeutics Inc. | 0.56 | -1.70% | $18.63M | vs QNCX |
| ESLAEstrella Immunopharma Inc. | 0.4175 | -0.43% | $18.16M | vs QNCX |
Indexes, lists and sector
Quince Therapeutics stock FAQ
What is Quince Therapeutics's stock price today?
QNCX last traded at $29.36 as of Oct 8, 4:00 PM EDT, up 9.88% on the day. Prices are delayed at least 15 minutes.
Does Quince Therapeutics pay a dividend?
No. Quince Therapeutics does not currently pay a regular cash dividend.
Has QNCX ever split its stock?
Yes. The most recent QNCX stock split was a 1-for-20 split on Jun 30, 2026, one of 2 splits on record.
What is the QNCX 52-week high?
The 52-week high for QNCX is $910.00 and the 52-week low is $15.10. The stock is currently 96.8% below its high.